HC
Therapeutic Areas
Zhimeng Biopharma Pipeline
| Drug | Indication | Phase |
|---|---|---|
| ZM-H1505R | Chronic Hepatitis B | Phase 1 |
| Undisclosed CAM | Chronic Hepatitis B | Clinical |
| Undisclosed Immunomodulator | Chronic Hepatitis B | Clinical |
| Undisclosed Program | Refractory Epilepsy | Clinical |
Leadership Team at Zhimeng Biopharma
ZZ
Zhijun Zhang, Ph.D.
Leadership Team
BL
Bo Liang, Ph.D.
Vice President of Chemistry
JJ
Jessie Jiang, Ph.D.
Senior Medical Director
RG
Ruoling Guo, Ph.D.
Senior Director, Global Clinical Operations
GL
Gang Liu, Ph.D.
Director, Chemistry, Manufacturing and Controls (CMC)